Navigation Links
Webster Ismus Cath 20-Pole Deflectable Catheter

ProductsWebster Ismus Cath 20-Pole Deflectable Catheter
Company Biosense Webster, a Johnson & Johnson Company
Item Webster Ismus Cath 20-Pole Deflectable Catheter
Features 
  • 2-12-2 mm electrode spacing facilitates positioning over a wide area of the atrium and may allow assessment of line of conduction block
  • Distal pair of electrodes permit pacing in the CS
  • 20 platinum iridium electrodes produce high-fidelity electrograms and permit simultaneous mapping of an extended area of the atrium without catheter repositioning
  • Patented thumb-slide handle allows efficient one-handed technique and enhances pushability
  • Deflectable catheter design features world-renowned Biosense Webster handling, including exceptional torqueability and tip stability
    • Description Biosense Webster offers a complete line of specialty 20-pole catheters for mapping in the atrium. The ISMUS CATH 20-pole deflectable catheter is designed for simple placement in the atrial isthmus. The pair of electrodes located on the catheter's distal tip permit pacing in the coronary sinus for confirmation of conduction block after ablation.
    Info Biosense Webster, a Johnson & Johnson Company
    Customer Service: (800) 729-9010
    Web site: http://www.biosensewebster.com/

    Related medicine products :

    1. Webster Ruler
    2. Webster Small Anatomy Fixed Curve Catheters
    3. Webster Supra CS Decapolar (Coronary Sinus Fixed Curve Catheters)
    4. Webster Small Anatomy Deflectable Catheters
    5. Webster Coronary Sinus Deflectable Catheters
    6. Webster Quadripolar Standard Deflectable Catheters
    7. Webster Octapolar Standard Deflectable Catheters
    8. Webster Quadrapolar Standard Deflectable Catheters
    9. Webster Decapolar Standard Deflectable Catheters
    10. Webster Decapolar Coronary Sinus Deflectable Catheters
    11. Webster Parahisian octapolar catheter
    For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines
    ...® T helps provide protection to the exposed ai...extremely lightweight making it ideal for active y...of heat and moisture recovery, it ensures patient ...Es and filters have ISO standard tapered ends to a...
    Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
    Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
    Medicine Products:
    (Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
    (Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
    (Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
    (Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
    Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
    ...i and his team from Wake Forest University Baptist... brain tumor – glioblastoma multiforme. The scient... protein in the brain cells were responsible for s...in the Journal Molecular Cancer Research. Glioblas...
    ... most common cancers occurring in humans. A clinic... of Eloxatin drug with other chemotherapeutic canc... better prognosis and reduced recurrence in these ...y has proved a combination of Eloxatin with chemot...
    ... by Dr. Martine Roussel of the St. Jude Children’s...medulloblastoma, the most common malignant brain t...tomas are malignant tumors that are formed by cell... words by poorly developed brain cells. These tumo...
    ...ugh research scientists have for the first time b...ab into a type of cell that can give rise to organ...rtant advancement will help scientists to use stem...organs. The embryonic stem cells is almost like a ...
    Other Medicine News:Health News:Protein Markers for Identification of Brain Tumor 2Health News:Stem cells Can Generate Organs In Labs 2
    (Date:5/20/2008)...ceived positive results of nine month,PAINT trials.... The results unveiled during plenary sessio...0 /- Sahajanand Medical Technologies,...nd manufacturer of,drug-eluting stents, welcomed t... nine months results of PAINT trial (PercutAneous ...
    (Date:5/20/2008)...ected in second half of 2008 --,-- Presentation at...ence on, May 21st canceled; webcast of corporate ...holder Meeting on May 22nd at 9:30 a.m. PT --, SA...osciences, Inc.,(Nasdaq: RDEA ) today announced t...en-activated ERK kinase (MEK) inhibitor, RDEA119, ...
    (Date:5/20/2008)...rstCall/ -- An interim analysis of a,study present... (DDW),Conference found that, among patients at in...n annual fecal immunochemical (FIT) test, detectio... months earlier than would,have occurred during th...Detection of precancerous lesions in this group oc...
    (Date:5/20/2008)...re-FirstCall/ -- BioMarin,Pharmaceutical Inc. (Nas...patient has initiated treatment in the Phase 1 cli...ylalanine ammonia lyase) for the treatment of,phen...de enrollment in the,fourth quarter of 2008., "We...pe to address the,entire spectrum of PKU patients ...
    Breaking Medicine Technology:Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 2Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 3Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 3Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 5BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 3NSF awards Williams funding for high speed imaging faciltity 1569 1NSF awards Williams funding for high speed imaging faciltity 1569 2Why the switch stays on 1567 1Why the switch stays on 1567 2Why the switch stays on 1567 3Ireland Cancer Center researchers advance stem cell gene therapy 1565 1Ireland Cancer Center researchers advance stem cell gene therapy 1565 2Ireland Cancer Center researchers advance stem cell gene therapy 1565 3Light and sound the way forward for better medical imaging 8122 1Light and sound the way forward for better medical imaging 8122 2
    ..., 2007--A cervical cancer vaccine has shown 90%,ef...ncerous lesions,associated with the human papillom...de authors of an Article published early Online,an...16 and 18 account for 70% or more,cases of cervica...ic HPV types which can contribute to cervical canc...
    ...ceed with Development Program for Oral Compounds,t...BUSINESS WIRE)--July 2, 2007--Alkermes, Inc.,(Nasd...ults from a,clinical trial of ALKS 29 in alcohol d...pany plans to move forward with its,development pr...,dependence. ALKS 29 is a combination of two agent...
    Other Medicine Technology:Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4